Abstract:A number of studies have attempted to elucidate the association between mircoRNAs (miRNAs/miRs) and cancer-associated processes. The aim of the present study was to determine how miR-499a-5p intervenes in human osteosarcoma cell proliferation and differentiation. The cancerous tissues and adjacent non-cancerous tissues of 62 patients with osteosarcoma (OS) were collected. miRNA microarray analysis revealed that 29 miRNAs were upregulated while 26 were downregulated, among which miR-499a-5p expression was the most decreased. Western blot analysis and reverse transcription-quantitative polymerase chain reaction demonstrated that the mRNA and protein expression of miR-499a-5p was lower, while that of protein phosphatase 1D (PPM1D) was higher in OS tissues compared with expression levels in normal tissues. Furthermore, miR-499a-5p expression was markedly decreased in the metastatic tumors and in those at stage III+ IV compared with the non-metastatic tumors and those at stage I, respectively. In addition, following transfection of the human OS MG-63 cell line with an miR-499a-5p mimic, the expression of miR-499a-5p was elevated while the protein and mRNA expression of PPM1D was decreased. When combining these findings with the information obtained from the Targetscan predictive software, it was confirmed that PPM1D was targeted by miR-499a-5p. In MG-63 cells transfected with an miR-499a-5p mimic, PPM1D-associated downstream proteins phosphorylated protein kinase B (p-Akt) and phosphorylated glycogen synthase kinase 3 beta (p-GSK-3 beta) were significantly downregulated compared with the negative control (NC) group, while the expression of p-Akt and p-GSK-3 beta were significantly elevated in the tumor tissues compared with the adjacent non-tumor tissues. Simultaneously, the growth and proliferation activity of MG-63 cells were notably reduced when transfected with the miR-499a-5p mimic, compared with the NC group. Therefore, it may be concluded that miR-499a-5p suppresses OS cell proliferation and differentiation by targeting PPM1D through modulation of Akt/GSK-3 beta signaling.

Mir-548D-3p Inhibits Osteosarcoma by Downregulating KRAS

Hsa-miR-557 Inhibits Osteosarcoma Growth Through Targeting KRAS

microRNA-486 suppressed proliferation , migration and invasion of osteosarcoma cells via directly targeting SIRT 1

MicroRNA-211 inhibits tumor growth and invasion through directly targeting RUNX 2 in osteosarcoma

MicroRNA-133a Inhibits Osteosarcoma Cells Proliferation and Invasion Via Targeting IGF-1R

MicroRNA-455-3p Inhibits Osteosarcoma Progression Via HSF1 Downregulation

MicroRNA-506-3p inhibits osteosarcoma cell proliferation and metastasis by suppressing RAB3D expression

Mir-16-5p Suppresses Progression and Invasion of Osteosarcoma Via Targeting at Smad3

MicroRNA-199a-3p Is Downregulated in Human Osteosarcoma and Regulates Cell Proliferation and Migration

Mir-761 Inhibits Human Osteosarcoma Progression by Targeting CXCR1.

Mir-34c-3p Acts As A Tumor Suppressor Gene in Osteosarcoma by Targeting Marcks

Microrna-194 Suppresses Osteosarcoma Cell Proliferation and Metastasis in Vitro and in Vivo by Targeting CDH2 and IGF1R.

Mir-149-5p Inhibits Cell Growth by Regulating TWEAK/Fn14/PI3K/AKT Pathway and Predicts Favorable Survival in Human Osteosarcoma

Mir-203 Acts As a Tumor Suppressor Gene in Osteosarcoma by Regulating RAB22A

Tumor-Suppressing Effects of miR451 in Human Osteosarcoma

Microrna-499a-5p Inhibits Osteosarcoma Cell Proliferation And Differentiation By Targeting Protein Phosphatase 1d Through Protein Kinase B/Glycogen Synthase Kinase 3 Beta Signaling

MiR-598: A Tumor Suppressor with Biomarker Significance in Osteosarcoma

Mir-218 Suppresses the Proliferation of Osteosarcoma Through Downregulation of E2F2

Microrna Profiling Identifies Mir-195 Suppresses Osteosarcoma Cell Metastasis By Targeting Ccnd1

Tumor-Suppressing Effects of Mir-429 on Human Osteosarcoma

MiR-134-5p inhibits the malignant phenotypes of osteosarcoma via ITGB1/MMP2/PI3K/Akt pathway